Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Development and in-vitro evaluation of once daily tablet dosage form of loxoprofen sodium

Muhammad Zaman¹ , Rai Muhammad Sarfraz², Sherjeel Adnan¹, Asif Mahmood², Muhammad Hanif³, Junaid Qureshi⁴, Muhammad Taimoor Chaudhary⁵, Muhammad Abdullah Akram⁶, Irfan Bashir⁷

¹Faculty of Pharmacy, The University of Lahore, Lahore; ²Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur; ³Faculty of Pharmacy, Bahauddin Zakaryia University, Multan; ⁴Faculty of Pharmacy G.C. University Faisalabad, Faisalabad; ⁵Punjab Forensic Science Agency, Toxicology Unit, Lahore, Pakistan; ⁶Faculty of Pharmacy University of Sargodha, Sargodha, Pakistan; ⁷Faculty of Pharmacy University of Central Punjab, Lahore, Pakistan.

For correspondence:- Muhammad Zaman Email: m.zaman2157@gmail.com Tel:+923006095928

Received: 2 October 2014 Accepted: 28 June 2015 Published: 29 September 2015

Citation: Zaman M, Sarfraz RM, Adnan S, Mahmood A, Hanif M, Qureshi J, et al. Development and in-vitro evaluation of once daily tablet dosage form of loxoprofen sodium. Trop J Pharm Res 2015; 14(9):1557-1563 doi: 10.4314/tjpr.v14i9.3

© 2015 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To formulate and characterize once daily controlled release tablet of loxoprofen sodium.

Methods: Eudragit RS-100, hydroxylpropyl methylcellulose (HPMC) and pectin were used as release retarding polymers. All the formulations were prepared by direct compression method. Various pre-compression studies were carried out to determine Hausner’s ratio, Carr’s index, angle of repose, bulk density and tapped density Differential scanning calorimetry (DSC) studies and also post-compression studies to evaluate hardness, friability, weight variation, drug content, in-vitro drug release were conducted on the tablets. The drug release data were subjected to kinetic models, including zero order, first order, Hixon Crowell, Higuchi and Korsmeyer-Peppas.

Results: Compressibility index (7.6 ± 1.32 - 12.5 ± 1.43%), Hausner’s ratio (1.08 ± 0.04 - 1.14 ± 0.03), angle of repose (27.78 ± 0.47 - 30.49 ± 0.46°), hardness (6.25 ± 0.27 - 7.21±0.21 kg/cm2), friability (0.14 ± 0.06 - 0.28 ± 0.0 %), weight variation (249.5 ± 2.09 - 251.35 ± 2.41 mg) and drug content (97.30 ± 0.28 - 103.70 ± 0.31 %) were within generally accepted limits for the pre-and post-compression formulations, respectively. The tablets having the maximum amount of among the three polymers tested as matrix materials, HPMC, represented by F3 tablets, exerted better sustained release properties after 12 h. Release pattern was more of Fickian diffusion followed by Higuchi mechanism.

Conclusion: The release of the loxoprofen sodium was optimized up to 12 h.

Keywords: Loxoprofen, Sustained release, hydroxypropyl methylcelluose, Pectin, Eudragit, Matrix tablets